BAD and breast cancer: We showed that in primary breast cancer, elevated BAD levels correlated with a 3.7-fold increased likelihood of patient survival and was a better prognostic indicator than tumor grade, HER2 or estrogen receptor suggesting a causal contribution to tumor suppression [13].